Skip to content
Phoenix PharamLabs Logo Phoenix PharamLabs Logo Phoenix PharamLabs Logo
  • Home
  • Technology
  • I.P.
  • Strategy
  • News & Event
  • Team
  • Contact

Checkout

CheckoutPPLadmin2025-04-13T07:02:47+00:00

Phoenix PharmaLabs welcomes inquiries by organizations seeking a beneficial relationship. Please contact us to explore potential opportunities.

LEARN MORE ABOUT US

Connect with us!

Contact Phoenix PharmaLabs™

999 West 1500 South, 600. Woods Cross, UT 84087

Phone: 312-943-1123

SITE MAP

  • Blog
  • Cart
  • Chantal Deziel, B.Sc, MBA
  • Checkout
  • CHRIS TEW – Vice President and Board Member
  • Contact us 2
  • Daniel E. Levy, Ph.D. – Consultant, Chemical Synthesis and Manufacturing Scale-up
  • David Heal PhD, DSc, FRSC, HonFBPhS – Consultant, Regulatory Affairs
  • Demo
  • HOME
  • Home 2
  • I.P – INTELLECTUAL PROPERTY
  • James R Myer. BS, DABT – Consultant, Toxicology
  • JOHN A. LAWSON, Ph.D. – Founder, Chairman & Chief Scientific Officer
  • LAWRENCE TOLL PH.D. – Founder, Chief Neuropharmacologist & Board Member
  • Mei-Chuan (Holden) Ko, Ph.D. – Consultant, NHP Studies
  • My account
  • Shop
  • STRATEGY 2
  • Team 2
  • Technology 2
  • TIMMY CHOU – Vice President, CFO & Board Member
  • Timothy P. Bradshaw, Ph.D. – Consultant, Preclinical and Clinical Trial Planning
  • WILLIAM CROSSMAN – President, CEO & Board Member
  • TECHNOLOGY
  • I.P.
  • STRATEGY
  • TEAM
  • #killpainnotpeople
  • CONTACT US
© Copyright 2022 - Phoenix Pharmalabs
Page load link

Mr. Crossman is responsible for the overall management of the Company and the creation, planning and execution of business and financial strategies and corporate development activities, including capital generation.
Crossman is a senior management professional with international and domestic experience as CEO, COO and CFO of enterprises ranging from entrepreneurial start-ups to Fortune 500 level companies. He has a proven track record of successfully commercializing various emerging technologies including manufacturing and industrial systems, computer software, marine bioremediation, nanotechnology and life sciences.

Mr.Crossman has assisted numerous early-stage companies to refine business strategies, commercialize new products, raise capital, license technologies, scale revenues and production, and expand into global markets. As CEO of ISOPur Fluid Technologies, Crossman led the company from product introduction to global growth with expanding applications in multiple vertical markets. Important strategic alliances were developed with Siemens, BHP, Atlas Copco, Hess, Sanwa Shoko and others, creating a platform for continued strong growth.

The value of the founding shareholders’ common stock increased more than tenfold in less than three years under Crossman’s leadership. As CFO of Otis Elevator Company – Asia Pacific Operations, Crossman evaluated, negotiated and developed acquisitions, joint ventures and major capital investments in China, Japan, Korea, India, Southeast Asia, and Australia. Mr. Crossman contributed to profit growth of 20% per year and market share gains of 1% per year in this mature multi-billion dollar operation spanning 23 countries, despite aggressive competition from large Asian conglomerates. The joint ventures that he helped developed in China are among the most profitable operations of United Technologies Corp today. Bill holds a BS degree from the U.S. Merchant Marine Academy at Kings Point and a MBA from the Haas School of Business at the University of California – Berkeley.

Go to Top